CTOs on the Move

University of Maryland Medical System

www.umms.org

 
The University of Maryland Medical System (UMMS) is a university-based regional health care system focused on serving the health care needs of Maryland. We bring innovation, discovery and research to the care we provide all while educating the state`s future physicians and health care professionals through our partnership with the University of Maryland School of Medicine and the UM Schools of Nursing, Pharmacy, Social Work and Dentistry in Baltimore. As one of the largest private employers in the state, the health system`s 25,000 employees and 4,000 affiliated physicians provide primary and specialty care in more than 150 locations and at 13 hospitals. UMMS` ...
  • Number of Employees: 5K-10K
  • Annual Revenue: > $1 Billion
  • www.umms.org
  • 250 W. Pratt Street
    Baltimore, MD USA 21201
  • Phone: 410.328.2450

Executives

Name Title Contact Details

Similar Companies

East Tennessee Behavioral Health

East Tennessee Behavioral Health is a hospital and treatment facility for adolescents and adults struggling with mental health concerns such as anxiety disorders, depression, bipolar disorder, and posttraumatic stress disorder (PTSD).

Integrity Medicolegal Ents

Integrity Medicolegal Ents is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cavapharma

Cavapharma is a Kirkland, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Pathfinder Solutions PBC

Pathfinder Solutions is a company that provides a fully integrated technology tool that enables connection and collaboration with individuals and their support teams for addiction and substance use disorder recovery.

Oklahoma Medical Research Foundation

Established in 1946, OMRF is an independent, nonprofit biomedical research institute with more than 450 staff and over 50 labs studying cancer, heart disease, autoimmune disorders, and diseases of aging. Breakthroughs in our labs have led to three FDA-approved drugs, including the first targeted therapy approved in the U.S. for sickle cell disease and the first approved treatment for neuromyelitis optica spectrum disorder, a rare autoimmune disease. OMRF`s critical research is helping people live longer, healthier lives, one discovery at a time. Along the way, OMRF has garnered worldwide media attention, from leading scientific publications like The New England Journal of Medicine and Science to The New York Times and The Wall Street Journal. By pushing the boundaries of biomedical science, our researchers are helping to win the war against human disease, one discovery at a time.